Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use

Identification of self and non-self antigens implicated in autoimmune disease

Human schwannoma cell line

IMMUNE RESPONSES AGAINST HPV ANTIGENS ELICITED BY COMPOSITIONS COMPRISING AN HPV ANTIGEN AND A STRESS PROTEIN OR AN EXPRESSION VECTOR CAPABLE OF EXPRESSION OF THESE PROTEINS

Detection method for human pappilomavirus (HPV) and its application in cervical cancer

HPV 16 peptide vaccine for head and neck cancer

Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses

Human papillomavirus polypeptides and immunogenic compositions

Adenoviral expression vector comprising a CD40L fusion protein adapted to elicit cellular immunity

VACCINE

Tat-Based vaccine Compositions and Methods of Making and Using Same

Vaccine composition comprising virus-like particles of human papillomavirus

Peptide antigen of human papillomavirus type 16 and application thereof

HPV vaccine comprising peptides from host cell proteins

Stable (fixed) forms of viral capsid proteins, and viral capsid protein fusions, preferably papillomavirus L1 proteins, and uses thereof

Modified HPV E6 and E7 genes and proteins useful for vaccination

MODIFIED HPV E6 AND E7 GENES AND PROTEINS USEFUL FOR VACCINATION

Genetic immunization against cervical carcinoma

Human papilloma virus immunoreactive peptides

Method for assembling a polymer-biologic delivery composition

Papilloma virus vaccine

HPV CD8+ T-cell epitopes

Antigens

Methods and compositions for treating cervical cancer

Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof. therapeutic uses thereof

Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions

Method of making a genetically modified mammalian cell

Cd4+ human papillomavirus (hpv) epitopes

Optimized expression of HPV 58 L1 in yeast

Specificity exchangers that redirect antibodies to a pathogen

Molecular vaccines employing nucleic acid encoding anti-apoptotic proteins

Vaccine

Mammalian cell lines for increasing longevity and protein yield from a cell culture

Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions

Molecule

Self-assembling recombinant papillomavirus capsid proteins

Packaging of immunostimulatory oligonucleotides into virus-like particles: method of preparation and use

Hpv-16 and-18 l1 vlp vaccine

Packaged virus-like particles

Compositions and methods for treating human papillomavirus mediated disease

Optimized expression of HPV 45 L1 in yeast

Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector

Non-immunosuppressive immunogenic or vaccine composition comprising a mutated E7 protein of the HPV-16 virus

Peptides for the treatment of cancer associated with the human papilloma virus (HPV) and other epithelial tumors

Methods and compositions for treatment of viral lnfection

MAGE-A3/HPV 16 peptide vaccines for head and neck cancer

Virus-like particles for the induction of autoantibodies

Compositions and methods for enhancing the immunogenicity of antigens

Papilloma virus capsomere vaccine formulations and methods of use

Flexible vaccine assembly and vaccine delivery platform

Vectors, cell lines and their use in obtaining extended episomal maintenance replication of hybrid plasmids and expression of gene products

CD8 T cell epitopes in HPV 16 E6 and E7 proteins and uses thereof

Optimized expression of HPV31 L1 in yeast

Vaccine

Compounds and methods of early diagnosis of cervical cancer and genital condyloma with HPV, CHSP60 tumor suppressor H-Ras, K-Ras and PTEN derived peptides modified

Papilloma virus-like particles, fusion proteins as well as processes for their production

Use of immunogenic immunosuppressive and/or angiogenic proteins which have been rendered inactive, process for their preparation and pharmaceutical or vaccinal uses

Cell surface expression vector of sars virus antigen and microorganisms transformed thereby

Chimeric human papillomavirus (HPV) L1 molecules and uses therefor

Detection of nucleic acids from multiple types of human papillomaviruses

Peptides from the E2 proteins of human papillomaviruses 16 and 18 for detecting and/or diagnosing cervical and other human papillomavirus associated cancers

Mutated hpv-16e7 polypeptide, pharmaceutical composition comprising it and its preparation process

Specificity exchangers that redirect antibodies to a pathogen

Methods and materials for treating human papillomavirus infections

Fusion protein for inhibiting cervical cancer

Chimaeric human papillomavirus 16 I1 virus like particles and a method for preparing the particles

Virus-like particle containing a dengue virus recombinant replicon

Human papillomavirus polypeptides and immunogenic compositions

Regions of papilloma virus E1 helicase involved in E1 oligomerization

Vaccine

Flexible vaccine assembly and vaccine delivery platform

Superior molecular vaccine based on self-replicating RNA, suicidal DNA or naked DNA vector, that links antigen with polypeptide that promotes antigen presentation

Vector for anti-HPV vaccine and transformed microorganism by the vector

Papilloma virus truncated L1 protein and fusion protein constructs

Treatment of papillomavirus infections

Mixed Virus-like particles

Peptides from the E7 protein of human papilloma viruses 16 and 18 for detecting and/or diagnosing cervical and other human papilloma virus associated cancers

Heat shock protein-based vaccines and immunotherapies

HPV CD8+ T-cell epitopes

Vaccine composition comprising virus-like particles of human papillomavirus

Antitumoral composition based on immunogenic polypeptide with modified cell location

Derivatized oligonucleotides having improved uptake and other properties

Transgenic animal model for the treatment of skin tumors

Human papillomavirus inhibitors

Optimization of gene sequences of chimeric virus-like particles for expression in insect cells

Vaccine using papilloma virus e proteins delivered by viral vector

Nucleic acids encoding polyepitope polypeptides

Chimeric papillomavirus-like particles

Complexes and methods of using same

Pharmaceutical compositions, and a method of preparing and isolating said pharmaceutical compositions, and use of said pharmaceutical compositions for prophylactic treatment of lesions and carcinomas

Induction of a Th1-like response in vitro

Compositions and methods for treating papillomavirus-infected cells

Immunogenic compositions of human papillomavirus and sera produced therefrom

Synthetic human papilloma virus genes

Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use

Synthetic virus-like particles with heterologous epitopes

Methods and compositions relating to HPV-associated pre-cancerous and cancerous growths, including CIN

Derivatized oligonucleotides having improved uptake and other properties

Immunological methodology for discerning human papillomavirus contemplating peptides from the E7 early coding region of HPV 16

Immunological methodology for discerning human papillomavirus contemplating peptides from the E7 early coding region of HPV 16

Papilloma virus sequences

Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins

Polyepitopic protein fragments of the E6 and E7 proteins of HPV, their production and their use particularly in vaccination

Vaccine

Medicament for preventing or treating papilloma virus-specific tumor

Papilloma virus capsomere vaccine formulations and methods of use

Inducer of apoptosis